Delivery Order SPE2DR25D6037-SPE2DR26FXL2B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,247.35 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) with a completion date of January 12, 2026. This firm fixed-price delivery order, awarded on January 9, 2026, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $8,841.30 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract type. The award was issued on January 27, 2026, with an ultimate completion date of January 28, 2026, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $43,104.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 29, 2026. This firm fixed-price delivery order, which carries a completion deadline of January 30, 2026, was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and distribution hub....
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with a completion date of October 28, 2025, and performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,615.78 for Jardiance 10 mg tablets (90-count supply) on April 22, 2025, with an ultimate completion date of April 23, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, leveraging the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $8,755.66 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). The contract was competitively awarded without set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of December 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,873.63 on January 21, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) to support federal medical procurement needs. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open and competitive procurement. The funding agency is the Defense Logistics Agency...
- SPE2DR25D6037Indefinite Delivery Contract
- SPE2DR25D6037-SPE2DR26FXL2BDelivery Order
The Defense Logistics Agency awarded a $7,110.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 30, 2026, with an ultimate completion date of February 2, 2026. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that serves as the primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical procurement ecosystem, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The firm fixed-price delivery order structure and competitive award reflect the contractor's ability to meet federal procurement requirements efficiently while supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through DLA's comprehensive pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 1/29/26 |